What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001489933
Total reported value
$3.9B
$3.9B
34 檔
31.4%
In Q2 2025, DME Capital Management, LP's U.S. equity holdings reached a combined market value of $3.9B, distributed across 34 disclosed stock positions.
During Q2 2025, DME Capital Management, LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GRBK | Green Brick Partners Inc | Stock-Other | 25.59% | +0.27% | — | |
| 2 | FLR | Fluor CORP | Stock-Industrials | 8.42% | -0.70% | — | |
| 3 | CNR | Core Natural Resources Inc | Stock-Energy | 6.46% | -1.43% | -2.40% | |
| 4 | BHF | Brighthouse Financial Inc | Stock-Financials | 6.38% | -0.73% | -1.46% | |
| 5 | KD | Kyndryl Holdings Inc | Stock-Tech | 5.97% | — | -19.92% | |
| 6 | PENN | Penn Entertainment Inc | Stock-Consumer Disc | 5.76% | +0.35% | +19.56% | |
| 7 | CNH | CNH Industrial N.V. | Stock-Industrials | 4.39% | -0.24% | -2.52% | |
| 8 | GPK | Graphic Packaging Holding Co | Stock-Consumer Disc | 4.26% | -0.14% | +349.43% | |
| 9 | DHT | DHT Holdings, Inc. | Stock-Other | 3.54% | -0.89% | +15.28% | |
| 10 | TECK | Teck Resources Ltd-cls B | Stock-Materials | 3.47% | — | — | |
| 11 | HPQ | Hp Inc | Stock-Tech | 3.17% | — | — | |
| 12 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 2.72% | -0.25% | +565.04% | |
| 13 | CPRI | Capri Holdings Limited | Stock-Consumer Disc | 2.65% | -0.43% | — | |
| 14 | LBTYA | Liberty Global Ltd. | Stock-Other | 2.25% | -0.44% | — | |
| 15 | GLD | Spdr Gold Shares | ETF-Commodities | 2.22% | -0.55% | -5.96% | |
| 16 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 2.21% | +0.08% | -16.36% | |
| 17 | WFRD | Weatherford International plc | Stock-Energy | 2.08% | -0.43% | EXIT | |
| 18 | CNC | Centene CORP | Stock-Healthcare | 1.96% | -0.09% | +53.25% | |
| 19 | SDRL | Seadrill Limited | Stock-Other | 1.79% | — | — | |
| 20 | CI | THE Cigna Group | Stock-Healthcare | 1.33% | -0.12% | — | |
| 21 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 0.84% | +0.01% | +615.71% | |
| 22 | VSXY | Victoria's Secret & Co | Stock-Consumer Disc | 0.71% | -3.28% | EXIT | |
| 23 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 0.58% | -0.08% | — | |
| 24 | COYA | Coya Therapeutics Inc | Stock-Other | 0.41% | +0.06% | — | |
| 25 | SNX | TD Synnex CORP | Stock-Tech | 0.19% | +0.07% | -28.01% | |
| 26 | GDX | Vaneck Gold Miners ETF | ETF-Commodities | 0.17% | — | — | |
| 27 | OIH | Vaneck Oil Services ETF | ETF-Other | 0.16% | — | +28.96% | |
| 28 | SHC | Sotera Health Co | Stock-Other | 0.11% | +0.95% | — | |
| 29 | GPRO | Gopro Inc-class A | Stock-Other | 0.09% | -0.01% | — | |
| 30 | PTON | Peloton Interactive Inc-a | Stock-Consumer Disc | 0.05% | -1.36% | EXIT | |
| 31 | GANX | Gain Therapeutics Inc | Stock-Other | 0.04% | — | — | |
| 32 | NUVB | Nuvation Bio Inc | Stock-Other | — | +0.01% | — | |
| 33 | NUVB-WS | Nuvation Bio Inc -cw27 | Stock-Other | — | — | — | |
| 34 | ✓ | Katapult Holdings Inc | Stock-Other | — | — | EXIT |
According to official SEC Form 13F filings, DME Capital Management, LP reported a total U.S. public equity portfolio value of $3.9B across 34 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GRBK, FLR, CNR) accounted for 31.4% of total reported equity market value during Q2 2025.
During Q2 2025, DME Capital Management, LP's top holdings by market value included GRBK (25.6%)、FLR (8.4%)、CNR (6.5%). The largest single position, GRBK, represented 25.6% of total portfolio value.
In Q2 2025, DME Capital Management, LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.